Petco Health and Wellness Bolsa (NASDAQ: WOOF)

Últimas noticias sobre Petco Health and Wellness (NASDAQ:WOOF) Bolsa

PETCO HEALTH AND WELLNESS CO

Petco Health and Wellness

Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.

Petco Health and Wellness Company, Inc. - Class A Common Stock

Petco Health and Wellness Co Inc

WOOF

<h3>Companies Reporting Before The Bell</h3>
• Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) is estimated to report quarterly loss at $5.00 per share on revenue of $5.60 million. 
• Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) is projected to report quarterly earnings at $2.18 per share on revenue of $8.23 billion. 
• Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $3.20 billion. 
• Titan America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTAM#NYSE">TTAM</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $384.72 million. 
• Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) is likely to report quarterly earnings at $1.06 per share on revenue of $2.60 billion. 
• SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) is expected to report quarterly loss at $0.03 per share on revenue of $202.71 million. 
• REX American Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REX#NYSE">REX</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $152.00 million. 
• CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $358 thousand. 
• Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $80.10 million. 
• JinkoSolar Holding Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) is estimated to report quarterly loss at $0.46 per share on revenue of $3.59 billion. 
• BRP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) is expected to report quarterly earnings at $0.62 per share on revenue of $1.35 billion. 
• Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) is expected to report quarterly loss at $0.14 per share on revenue of $88.50 million. 
• Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) is expected to report quarterly loss at $2.94 per share on revenue of $4.28 million. 
• Cheetah Mobile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCM#NYSE">CMCM</a>) is expected to report earnings for its fourth quarter. 
• Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is projected to report quarterly earnings at $1.48 per share on revenue of $1.51 billion. 
• Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is projected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) is estimated to report earnings for its fourth quarter. 
• Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) is likely to report earnings for its fourth quarter. 
• TAT Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) is likely to report earnings for its fourth quarter. 
• Envela (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELA#AMEX">ELA</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $40.63 million. 
• 3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) is projected to report quarterly loss at $0.11 per share on revenue of $114.96 million. 
• BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) is projected to report quarterly loss at $0.87 per share on revenue of $20 thousand. 
• Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) is projected to report earnings for its fourth quarter. 
• Durect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRRX#NASDAQ">DRRX</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $6.91 million. 
• Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $14.21 million. 
• Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is expected to report earnings for its fourth quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is projected to report quarterly loss at $0.03 per share on revenue of $33.09 million. 
• Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) is projected to report quarterly earnings at $1.13 per share on revenue of $1.97 billion. 
• Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $2.10 million. 
• H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $797.68 million. 
• Dyadic International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) is expected to report quarterly loss at $0.06 per share on revenue of $1.35 million. 
• Usio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USIO#NASDAQ">USIO</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $21.40 million. 
• Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) is estimated to report quarterly earnings at $1.27 per share on revenue of $276.82 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $3.01 per share on revenue of $2.47 billion. 
• Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is projected to report earnings for its fourth quarter. 
• Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $790.90 million. 
• Guardian Pharmacy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRDN#NYSE">GRDN</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $320.52 million. 
• Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) is expected to report quarterly loss at $0.26 per share on revenue of $232 thousand. 
• MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is projected to report quarterly earnings at $0.44 per share on revenue of $918.88 million. 
• Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $87.50 million. 
• Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) is estimated to report earnings for its Fiscal Year 2024. 
• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $1.56 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ALUR

ALVO

BCDA

CATX

CHWY

CLGN

CMCM

CNXC

CTAS

DERM

DLTR

DOOO

DRRX

DTIL

DYAI

GRDN

ITRG

MLKN

MVIS

OXBR

PAYX

SAIL

SNAL

Spruce Power Holding Corporation Class A Common Stock

SPRU

TATT

TTAM

USIO

VRNT

ZEPP

Earnings Scheduled For March 26, 2025

WIIM

AMZN

BBWI

BIRK

BURL

CANG

CPRI

CVNA

DECK

LULU

REAL

SFIX

SHOO

SHOT

TSCO

ULTA

URBN

Shares of retail, apparel, and e-commerce companies are trading higher amid overall market strength on reports of potentially narrowed or targeted tariffs, which may be easing investor concerns.

Citigroup analyst Steven Zaccone maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Neutral and lowers the price target from $5 to $2.75.

News

Price Target

Analyst Ratings

Citigroup Maintains Neutral on Petco Health and Wellness, Lowers Price Target to $2.75

Petco Health and Wellness shares are trading lower. The company announced leadership changes at the company including the CFO.

Management

Petco Appoints Sabrina Simmons Chief Financial Officer, Effective February 17,2025

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Petco Health and Wellness Company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)</h3>
<ul>
<li>On Jan. 21, Morgan Stanley analyst Simeon Gutman maintained Petco Health and Wellness with an Equal-Weight rating and lowered the price target from $6 to $5. The company's stock fell around 23% over the past month and has a <a href="https://www.benzinga.com/quote/WOOF">52-week low of $1.42</a>.</li>
<li>RSI Value: 27.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>WOOF Price Action: Shares of Petco Health fell 3.9% to close at $2.94 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021425&amp;t=be2bearmibe3na1">WOOF news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="856" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041122/image-130.png" alt="" class="wp-image-782659" style="width:621px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041122/image-130.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041122/image-130-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041122/image-130-768x721.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">Hanesbrands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HBI#NYSE">HBI</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Feb. 13, Hanesbrands reported worse-than-expected fourth-quarter sales results and issued FY25 sales guidance below estimates. Also, the company issued first-quarter guidance below estimates. HanesBrands also announced today that Steve Bratspies will depart as Chief Executive Officer at the end of 2025, or upon the appointment of his successor. Bratspies will step down from the Board concurrent with the end of his tenure as CEO. The company's stock fell around 26% over the past month and <a href="https://www.benzinga.com/quote/HBI">has a 52-week low</a> of $4.06.</li>
<li>RSI Value: 15.4</li>
<li>HBI Price Action: Shares of Hanesbrands fell 18.5% to close at $6.25 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021425&amp;t=be2bearmibe3na1">HBI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="922" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041201/image-2-42.png" alt="" class="wp-image-782660" style="width:574px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041201/image-2-42.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041201/image-2-42-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041201/image-2-42-768x701.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">Hyatt Hotels Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>)</h3>
<ul>
<li>On Feb. 13, the company reported fourth-quarter adjusted earnings per share of 42 cents, missing the street view of 78 cents. Quarterly sales of $1.602 billion missed the analyst consensus estimate of $1.658 billion. The company's stock fell around 12% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/H">low of $125.78.</a></li>
<li>RSI Value: 26.3</li>
<li>H Price Action: Shares of Hyatt fell 1.1% to close at $279.45 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021425&amp;t=be2bearmibe3na1">breakout in H share</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021425&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041316/image-131.png" alt="" class="wp-image-782664" style="width:543px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041316/image-131.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041316/image-131-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/14041316/image-131-768x719.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43692962/top-3-consumer-stocks-you-may-want-to-dump-in-february">Top 3 Consumer Stocks You May Want To Dump In February</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

Top 3 Consumer Stocks That Could Blast Off This Month

Morgan Stanley analyst Simeon Gutman maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and lowers the price target from $6 to $5.

Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Lowers Price Target to $5

RBC Capital analyst Steven Shemesh reiterates Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and maintains $6 price target.

Reiteration

RBC Capital Reiterates Outperform on Petco Health and Wellness, Maintains $6 Price Target

<h3>Gainers</h3>
<ul>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock increased by 38.6% to $3.19 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) stock moved upwards by 22.44% to $6.0. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares rose 18.75% to $4.59. The market value of their outstanding shares is at $2.8 million. </li>
<li>American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) stock moved upwards by 12.01% to $12.21. The market value of their outstanding shares is at $156.7 million. The company's, Q2 earnings came out yesterday. </li>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) shares moved upwards by 10.19% to $379.97. The market value of their outstanding shares is at $46.6 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) stock increased by 9.17% to $22.01. The company's market cap stands at $421.3 million. As per the news, the Q3 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) stock declined by 16.7% to $11.35 during Friday's pre-market session. The company's market cap stands at $509.0 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) stock fell 15.89% to $5.4. The market value of their outstanding shares is at $624.3 million. </li>
<li>United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) stock fell 15.74% to $5.14. The company's market cap stands at $248.8 million. </li>
<li>EpicQuest Education Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) shares decreased by 8.92% to $0.92. The company's market cap stands at $11.9 million. </li>
<li>GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) shares declined by 8.7% to $22.15. The market value of their outstanding shares is at $907.5 million. </li>
<li>Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) shares fell 8.23% to $30.0. The market value of their outstanding shares is at $814.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AOUT

EEIQ

JFBR

SCVL

SWBI

SWIM

ZUMZ

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported better-than-expected results for its <a href="https://www.benzinga.com/quote/WOOF/earnings">third quarter on Thursday.</a>
The company posted a quarterly loss of 1 cents per share versus market estimates of a loss of 4 cents per share. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion.
&#8220;Our third quarter results demonstrate the meaningful progress we&#8217;re making to strengthen our retail fundamentals to drive sustainable, profitable growth,&#8221; said Joel Anderson, Petco&#8217;s Chief Executive Officer. &#8220;While there is more work to do, our improving results increase our conviction that we are on the right path to position Petco to win long-term. Our entire organization is focused on driving profitability and free cash flow, and I&#8217;m confident we&#8217;re set up for a solid finish to 2024.&#8221;
Petco Health shares gained 16.9% to trade at $5.73 on Friday.
These analysts made changes to their price targets on Petco Health following earnings announcement.
<ul>
<li>Wells Fargo analyst Zachary Fadem maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $5.</li>
<li>RBC Capital analyst Steven Shemesh maintained the stock with an Outperform and boosted the price target from $5 to $6.</li>
<li>Morgan Stanley analyst Simeon Gutman maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $6.</li>
<li>Wedbush analyst Seth Basham maintained Petco Health and Wellness with an Outperform and boosted the price target from $5.5 to $6.</li>
</ul>
Considering buying WOOF stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="567" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png" alt="" class="wp-image-681107" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454.png 1173w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42364367/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

These Analysts Increase Their Forecasts On Petco Health and Wellness After Strong Q3 Results

Wedbush analyst Seth Basham maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5.5 to $6.

Wedbush Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

Morgan Stanley analyst Simeon Gutman maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $6.

Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $6

RBC Capital analyst Steven Shemesh maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5 to $6.

RBC Capital Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

Petco Health shares are trading higher after Wells Fargo raised its price target on the stock from $3 to $5.

7 analysts have expressed a variety of opinions on Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.36, a high estimate of $5.50, and a low estimate of $3.00. Witnessing a positive shift, the current average has risen by 10.1% from the previous average price target of $3.96.
<img src="https://www.benzinga.com/files/images/story/2024/1733497339_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Petco Health and Wellness among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$5.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$5.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$4.50</td>
<td>$4.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$4.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$3.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$3.00</td>
<td>$2.75</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Petco Health and Wellness. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Petco Health and Wellness's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Petco Health and Wellness's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Petco Health and Wellness Better</h2>
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Financial Milestones: Petco Health and Wellness's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 31 July, 2024, the company experienced a revenue decline of approximately -0.46%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Petco Health and Wellness's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -1.63%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Petco Health and Wellness's ROE stands out, surpassing industry averages. With an impressive ROE of -2.16%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.64, Petco Health and Wellness faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Petco Health and Wellness

Wells Fargo analyst Zachary Fadem maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $5.

Wells Fargo Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $5

The earnings results for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Overview of Past Earnings</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness: Q3 Earnings Insights

Petco Health and Wellness shares are trading higher after the company announced better-than-expected Q3 financial results.

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Summary: Petco Health and Wellness Q3

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Q3 Earnings Assessment

Press Releases

Petco Names Joel D. Anderson as Chief Executive Officer

Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Petco Health and Wellness Company, Inc. to Host Second Quarter 2024 Earnings Conference Call on September 10, 2024

Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results

Petco Health and Wellness Company, Inc. to Host Third Quarter 2024 Earnings Conference Call on December 5, 2024

Petco Names Joe Venezia Chief Revenue Officer

Petco Health + Wellness Company, Inc. Reports Third Quarter 2024 Earnings Results

PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

Petco Health and Wellness Company, Inc. to Host Fourth Quarter 2024 Earnings Conference Call on March 26, 2025

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

BARK

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

National Vision Holdings, Inc. - Common Stock

National Vision Holdings

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

Grove Collaborative Holdings, Inc. Class A Common Stock

Grove Collaborative Hldgs

MarineMax

Leslies

PetMed Express

Park Ha Biological Technology Co., Ltd. - ordinary shares

Park Ha Biological Tech

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Comments

Petco Health and Wellness

Noticias

Últimas noticias sobre Petco Health and Wellness (NASDAQ:WOOF) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL